Skip to main content
. 2022 Feb 7;5(2):675–690. doi: 10.1021/acsabm.1c01107

Table 3. In Vivo Pathological Results.

group nuclear pleomorphism mitosis index invasion
cancer control 3 3 3
CIS+EPI 3 3 2
NCE 3 2 2
FPNCE 2 1 1